Close

Regeneron (REGN), Sanofi (SNY) Announce Positive Top-Line Phase 3 ODYSSEY Data

July 30, 2014 8:01 AM EDT Send to a Friend
Regeneron (NASDAQ: REGN) and Sanofi (NYSE: SNY) announced that nine new Phase 3 ODYSSEY trials of alirocumab in people with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login